Clinical Trial Update: ctDNA-Informed Management of Early-Stage Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ctDNA-informed management for early-stage rectal cancer; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: University of California, Davis | Conditions: Rectal Adenocarcinoma, Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING